[1] 段华, 甘露. 宫腔粘连子宫腔整复手术质量控制[J]. 中国实用妇科与产科杂志, 2022, 38(1): 36-40. [2] CARBONNEL M, PIRTEA P, DE ZIEGLER D, et al. Uterine factors in recurrent pregnancy losses[J]. Fertil Steril, 2021, 115(3): 538-545.
[2] 潘宁宁, 李蓉. 从生育力保护角度探讨宫腔粘连的围手术期治疗[J]. 中国实用妇科与产科杂志, 2022, 38(11):1092-1096.
[3] SUN H M, LU Y H, QI Q, et al. Advanced age - a critical risk factor for recurrent miscarriage[J]. Glob Health Med, 2023, 5(5):316-318. doi:  10.35772/ghm.2023.01066
[4] 厉姗姗, 刘杰, 宋莹. 优思明和吩吗通预防重复人工流产术后宫腔粘连效果对比分析[J]. 中国妇幼保健, 2020, 35(18):3456-3459.
[5] 中华医学会妇产科学分会. 宫腔粘连临床诊疗中国专家共识[J]. 中华妇产科杂志, 2015, 50(12):881-887. doi:  10.3760/cma.j.issn.0529-567x.2015.12.001
[6] 侯俊芳, 唐静, 张海霞. 中重度宫腔粘连术后应用不同剂量雌激素对预后的影响[J]. 深圳中西医结合杂志, 2021, 31(19):149-151.
[7] 韦凯伊, 麦虹, 廖雁, 等. 宫腔镜宫腔粘连分离术联合药物综合治疗中重度宫腔粘连不孕患者的临床疗效观察[J]. 大医生, 2022, 7(19):54-57. doi:  10.3969/j.issn.2096-2665.2022.19.dysh202219018
[8] 姚千红, 徐晓霞, 吴小欢. 补肾活血方联合雌孕激素预防清宫术后宫腔粘连的临床效果[J]. 中国妇幼保健, 2023, 38(24):4886-4889.
[9] 左海红, 章君华, 程文君. 复元祛瘀汤联合雌孕激素序贯疗法预防宫腔镜下宫腔粘连分离术后再粘连临床研究[J]. 新中医, 2023, 55(23):142-147.
[10] The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, mülllerian anomalies and intrauterine adhesions[J]. Fertil & Steril, 1988, 49(6): 944-955.
[11] 陈瑾. 育龄期妇女人工流产术后继发性不孕的危险因素[J]. 吉林医学, 2022, 43(12):3314-3316. doi:  10.3969/j.issn.1004-0412.2022.12.050
[12] ZHANG W J, FRENCH H, O’BRIEN M, et al. Incidence of intrauterine adhesions after hysteroscopic myomectomy in patients seeking fertility[J]. J Minim Invasive Gynecol, 2023, 30(10):805-812. doi:  10.1016/j.jmig.2023.05.013
[13] 刘姝岑, 朱雪红, 宾力, 等. 中国地区人工流产术及宫腔镜术后出现宫腔粘连危险因素的Meta分析[J]. 中国性科学, 2023, 32(1):93-97. doi:  10.3969/j.issn.1672-1993.2023.01.023
[14] KOU L F, JIANG X, XIAO S Y, et al. Therapeutic options and drug delivery strategies for the prevention of intrauterine adhesions[J]. J Control Release, 2020, 318:25-37. doi:  10.1016/j.jconrel.2019.12.007
[15] LEE W L, LIU C H, CHENG M, et al. Focus on the primary prevention of intrauterine adhesions: current concept and vision[J]. Int J Mol Sci, 2021, 22(10):5175. doi:  10.3390/ijms22105175
[16] WANG X Z, MA N N, SUN Q N, et al. Elevated NF-κB signaling in Asherman syndrome patients and animal models[J]. Oncotarget, 2017, 8(9):15399-15406. doi:  10.18632/oncotarget.14853
[17] DEMIR R, YABA A, HUPPERTZ B. Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation[J]. Acta Histochem, 2010, 112(3):203-214. doi:  10.1016/j.acthis.2009.04.004